A Swiss biotech firm developing a Covid treatment has seen its share price soar 38,000% this year ...United Arab Emirates

Swiss biotech firm Relief Therapeutics has seen its share price climb by nearly 38,000% so far this year, as it develops a drug focused on respiratory failure arising from severe Covid-19.

Hence then, the article about a swiss biotech firm developing a covid treatment has seen its share price soar 38 000 this year was published today ( Monday 14/12/2020 - 11:15 AM ) and is available on CNBC ( United Arab Emirates ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( A Swiss biotech firm developing a Covid treatment has seen its share price soar 38,000% this year )

Last updated : 14 Dec 2020 clock 11:15 AM

Also on site :

Israel and Hezbollah Truce Gives Oil Markets a Reason to Pause
Kuwait Says Oil Output Could Hit 2 Million Bpd Within a Week
Advita Ortho Highlights New Research on AI-Generated Shoulder Digital Twins and Surgical Navigation at CAOS 2026

A Swiss biotech firm developing a Covid treatment has seen its share price soar 38,000% this year ...United Arab Emirates

Fed governor spoke at Bank of America dinner during Fed’s ‘quiet period’

Belief that anyone can achieve the American Dream is fading, poll finds

EasySpanishTax.com Launches Simple DIY Modelo 210 Filing Solution for Non-Resident Property Owners in Spain

Solar Is the Cheapest Power in History, But States Are Retreating From It

itel is Living Proof of the Caribbean's Competitiveness in Global Outsourcing

Geographic Solutions Named in the Top 100 for the North America Inspiring Workplaces Awards

Why Lunar Helium-3 Mining Still Can't Compete With Earth

The Real Reason BP Is Retreating From the North Sea

Israel and Hezbollah Truce Gives Oil Markets a Reason to Pause

Bitmine Immersion Technologies kondigt een contant dividend van $0,1056 per aandeel aan op de 9,50% eeuwigdurende preferente aandelen van serie A

WTOP News Names ThunderCat Technology A Winner Of The Greater Washington area Top Workplaces 2026 Award

Russia Is Rationing Fuel in Moscow After Drone Strikes

Insta360 Luna Ultra Dual-Lens 8K Gimbal Camera and Mic Pro Announced; More Info at B&H

SIGGRAPH 2026 Computer Animation Festival Celebrates Global Storytelling, Alongside a Blockbuster Production Sessions Lineup

Kuwait Says Oil Output Could Hit 2 Million Bpd Within a Week